These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16777693

  • 21. [Limphomatous meningitis as recurrence site in Hodgkin's disease].
    Greco M, Valsecchi M, Niccodemi C, Presas J, Corrado C, Winkel M.
    Medicina (B Aires); 2006; 66(4):332-4. PubMed ID: 16977969
    [Abstract] [Full Text] [Related]

  • 22. Hodgkin's lymphoma of the uterus presenting as refractory pelvic inflammatory disease. A case report.
    Raggio ML, Bostrom SG, Harden EA.
    J Reprod Med; 1988 Oct; 33(10):827-30. PubMed ID: 3193414
    [Abstract] [Full Text] [Related]

  • 23. [Nephrotic syndrome in Hodgkin's disease].
    Miltényi Z, Keresztes K, Ujhelyi L, Kovács J, Illés A.
    Orv Hetil; 2005 Jun 19; 146(25):1357-60. PubMed ID: 16106759
    [Abstract] [Full Text] [Related]

  • 24. Solitary plaque on the scalp as a primary manifestation of Hodgkin lymphoma: a case report and review of the literature.
    Khalifeh I, Hughey LC, Huang CC, Reddy VV, Sellheyer K.
    J Cutan Pathol; 2009 Oct 19; 36 Suppl 1():80-5. PubMed ID: 19775396
    [Abstract] [Full Text] [Related]

  • 25. Unusual association of Hodgkin's disease and sarcoidosis.
    Simsek S, van Leuven F, Bronsveld W, Ooms GH, Groeneveld AB, de Graaff CS.
    Neth J Med; 2002 Dec 19; 60(11):438-40. PubMed ID: 12685492
    [Abstract] [Full Text] [Related]

  • 26. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2007 Oct 19; 40(7):651-8. PubMed ID: 17660837
    [Abstract] [Full Text] [Related]

  • 27. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
    Aydin S, Dührsen U, Nückel H.
    Ann Hematol; 2007 Apr 19; 86(4):271-6. PubMed ID: 17216473
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH, Li YX, Song YW, Jin J, Liu YP, Wang SL, Zhou LQ, Liu XF, Yu ZH, Han JZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 19; 28(3):218-21. PubMed ID: 16875611
    [Abstract] [Full Text] [Related]

  • 29. Unusual sites of Hodgkin's lymphoma: CASE 2. Hodgkin's lymphoma of the CNS masquerading as meningioma.
    Figueroa BE, Brown JR, Nascimento A, Fisher DC, Tuli S.
    J Clin Oncol; 2004 Oct 15; 22(20):4228-30. PubMed ID: 15483035
    [No Abstract] [Full Text] [Related]

  • 30. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
    Torjman L, Ladeb S, Lakhal A, Ben Othman T, Abdelkefi A, Ben Abdeladhim A.
    Tunis Med; 2007 Jan 15; 85(1):35-8. PubMed ID: 17424707
    [Abstract] [Full Text] [Related]

  • 31. Hodgkin's disease of the skin. A case report.
    Heyd J, Weissberg N, Gottschalk S.
    Cancer; 1989 Mar 01; 63(5):924-9. PubMed ID: 2644017
    [Abstract] [Full Text] [Related]

  • 32. Skin involvement in Hodgkin's disease.
    Smith JL, Butler JJ.
    Cancer; 1980 Jan 15; 45(2):354-61. PubMed ID: 7351017
    [Abstract] [Full Text] [Related]

  • 33. Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Mey UJ, Orlopp KS, Flieger D, Strehl JW, Ho AD, Hensel M, Bopp C, Gorschlüter M, Wilhelm M, Birkmann J, Kaiser U, Neubauer A, Florschütz A, Rabe C, Hahn C, Glasmacher AG, Schmidt-Wolf IG.
    Cancer Invest; 2006 Oct 15; 24(6):593-600. PubMed ID: 16982464
    [Abstract] [Full Text] [Related]

  • 34. Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171.
    Budman DR, Anderson J, Obrecht JP, Canellos GP, Creaven P, Norton L, Gottlieb A.
    Cancer Treat Rep; 1985 Jun 15; 69(6):719-20. PubMed ID: 3926312
    [No Abstract] [Full Text] [Related]

  • 35. Hodgkin lymphoma with cutaneous involvement.
    Hsia CC, Howson-Jan K, Rizkalla KS.
    Dermatol Online J; 2009 May 15; 15(5):5. PubMed ID: 19624983
    [Abstract] [Full Text] [Related]

  • 36. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 15; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 37. CNS involvement in Hodgkin's lymphoma.
    Re D, Fuchs M, Schober T, Engert A, Diehl V.
    J Clin Oncol; 2007 Jul 20; 25(21):3182. PubMed ID: 17634503
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May 20; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 40. Cutaneous manifestations of Hodgkin's disease.
    Arroyo A, Sánchez J, Vélez-García E.
    Cutis; 1983 Jul 20; 32(1):79-82. PubMed ID: 6884087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.